PG电子·(中国)官方网站

News & Trends

• 162019-10

  Salubris's first biological product "Recombinant Teriparatide for Injection" was approved for marketing

  Recently, Genemen Biotech (Suzhou) Co., Ltd., a subsidiary of Shenzhen Salubris Pharmaceuticals Co., Ltd., received the Drug Registration Approval Document of "Recombinant Teriparatide for Injection" (Xinfutai) approved and issued by National Medical

• 302019-04

  With the successful market launch of Pitavastatin Calcium Tablets, Salubris have involved in lipid-lowering, antihypertensive and antithrombotic field

  Recently, Salubris's Pitavastatin Calcium Tablets 2mg (trademark: Xinliming) was approved for market launch. So far, Salubris have involved in lipid-lowering, antihypertensive and antithrombotic filed, further strengthening its dominant position in t

• 062018-08

  Breaking news! Salubris's super product Taiyi (Ticagrelor) was approved for marketing!

  Exciting! Recently, Taiyi (Ticagrelor), a super product in cardiovascular field of Salubris Pharmaceuticals, was approved for marketing, winning the first place and taking the lead in the market.

• 192018-06

  Salubris invested in M&A of Huanchen Medical to strengthen the layout of devices in the cardiovascular field

  On June 8th, the signing ceremony of Salubris's investment and M&A with Suzhou Huanchen Medical Technology Co., Ltd. was held at Salubris Group Headquarters. Salubris will obtain 100% stock right of Suzhou Huanchen in stages with its own capital of R

• 302018-01

  The tide of capital increase welcomes a good start

  Recently, Salubris has successively increased its capital and invested in Sichuan Jinjiang Electronic Science and Technology Co., Ltd. ("Jinjiang Electronic") and KingstronBio (Changshu) Co., Ltd. ("KingstronBio").

• 022017-05

  Warmly congratulate Salubris on the formal establishment of its first American subsidiary

  On May 1, local time in Maryland, USA, Salubris Biotherapeutics, Inc., a wholly-owned subsidiary of Genekey Biotech (Chengdu) Co., Ltd., held its opening ceremony in Gaithersburg, Maryland, USA. Salubris Biotherapeutics, Inc. was the first American s